Profile data is unavailable for this security.
About the company
Rhythm Biosciences Ltd is an Australia-based medical diagnostics company. The Company is engaged in delivering simple, affordable blood tests for accurate and early detection of cancers. It is focused on improving patient outcomes through detection at the earliest possible stage, reducing the global burden of cancer and saving lives. The Company has developed ColoSTAT, a blood test for the detection of Colorectal Cancer (CRC). If diagnosed early, colorectal cancer is curable. The ColoSTAT Test-Kit measures five specific protein biomarkers that indicate the likelihood of CRC. The test is an alternative for individuals who are unable or unwilling to participate in current screening programs. It is being updated to meet the IVDR (In vitro diagnostic medical devices regulation) regulatory standards. It is focused on working with likeminded global partners to achieve commercialization and distribution of these simple solutions.
- Revenue in AUD (TTM)52.28k
- Net income in AUD-6.86m
- Incorporated2017
- Employees--
- LocationRhythm Biosciences LtdBio21 Institute30 Flemington Road, ParkvilleMELBOURNE 3010AustraliaAUS
- Phone+61 39614-0600
- Fax+61 39614-0550
- Websitehttps://www.rhythmbio.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zelira Therapeutics Ltd | 1.02m | -36.57m | 7.72m | 8.00 | -- | -- | -- | 7.54 | -3.22 | -3.22 | 0.0902 | -0.3979 | 0.0524 | 0.0609 | 5.06 | -- | -188.05 | -46.98 | -246.20 | -50.16 | 91.73 | -- | -3,587.90 | -1,063.82 | 0.424 | -6.78 | 3.35 | -- | -82.72 | -35.59 | -556.18 | -- | -- | -- |
| Island Pharmaceuticals Ltd | 4.72k | -2.86m | 9.90m | -- | -- | 6.51 | -- | 2,096.89 | -0.0318 | -0.0318 | 0.00005 | 0.012 | 0.002 | -- | 0.0104 | -- | -124.17 | -- | -173.37 | -- | -- | -- | -60,684.75 | -- | -- | -544.58 | 0.2174 | -- | -57.45 | -- | -1.20 | -- | -- | -- |
| Adalta Ltd | 1.78m | -5.38m | 11.52m | -- | -- | 5.57 | -- | 6.45 | -0.0111 | -0.0111 | 0.0036 | 0.0034 | 0.2682 | -- | 0.7681 | -- | -80.88 | -66.85 | -203.94 | -114.23 | -- | -- | -301.55 | -175.59 | -- | -51.02 | 0.5712 | -- | -49.47 | -13.04 | -10.93 | -- | -18.22 | -- |
| Algorae Pharmaceuticals Ltd | 125.20k | -2.10m | 11.81m | -- | -- | 3.92 | -- | 94.34 | -0.0013 | -0.0013 | 0.00008 | 0.0018 | 0.0338 | -- | 1.81 | -- | -56.60 | -47.73 | -61.85 | -54.26 | -- | -- | -1,673.77 | -865.45 | -- | -115.69 | 0.00 | -- | 197.95 | -30.46 | 0.5741 | -- | -- | -- |
| Patrys Ltd | 1.39m | -3.54m | 12.34m | 15.00 | -- | 3.55 | -- | 8.85 | -0.0017 | -0.0017 | 0.0007 | 0.0017 | 0.2386 | -- | 0.6665 | -- | -60.57 | -52.81 | -68.65 | -56.79 | -- | -- | -253.86 | -249.64 | -- | -- | 0.00 | -- | -51.11 | 10.55 | 49.88 | -- | -4.41 | -- |
| Chimeric Therapeutics Ltd | 0.00 | -12.53m | 12.51m | -- | -- | 4.97 | -- | -- | -0.0136 | -0.0136 | 0.00 | 0.0028 | 0.00 | -- | -- | -- | -66.56 | -- | -194.88 | -- | -- | -- | -- | -- | -- | -58.48 | 0.5228 | -- | -- | -- | 50.86 | -- | -- | -- |
| BPH Energy Ltd | 843.69k | 4.56m | 14.47m | 2.00k | 3.12 | 0.4674 | -- | 17.15 | 0.0039 | 0.0039 | 0.0008 | 0.0257 | 0.0333 | -- | 11.41 | -- | 17.98 | 5.12 | 18.58 | 5.50 | -- | -- | 539.93 | 238.65 | -- | -- | 0.0029 | -- | 177.48 | 24.84 | 433.96 | -- | -- | -- |
| Medlab Clinical Ltd | 366.64k | -3.94m | 15.04m | 14.00 | -- | -- | -- | 41.02 | -1.73 | -1.73 | 0.1606 | -0.3068 | 0.1069 | -- | 5.82 | -- | -103.72 | -55.07 | -240.52 | -69.75 | 84.77 | 52.86 | -970.74 | -335.43 | -- | -342.19 | -- | -- | -28.90 | -29.83 | 18.55 | -- | -30.00 | -- |
| Rhythm Biosciences Ltd | 52.28k | -6.86m | 15.41m | -- | -- | 17.77 | -- | 294.82 | -0.0301 | -0.0301 | 0.0002 | 0.0035 | 0.0114 | 1.91 | 1.02 | -- | -148.83 | -134.13 | -199.13 | -168.97 | -4,946.29 | -1,807.84 | -13,115.47 | -9,433.23 | 1.58 | -1,750.40 | 0.1589 | -- | -77.10 | -18.01 | 16.56 | -- | -5.69 | -- |
| BTC Health Ltd | 16.36k | 1.06m | 15.56m | 1.00 | 13.91 | 3.15 | 14.74 | 950.97 | 0.0035 | 0.0035 | 0.00005 | 0.0153 | 0.004 | -- | -- | -- | 26.09 | -21.22 | 27.32 | -22.60 | -- | -- | 6,450.37 | -3,306.65 | -- | -- | 0.00 | -- | 23.38 | -38.62 | 110.38 | -- | -- | -- |
| Alterity Therapeutics Ltd | 268.42k | -19.12m | 15.96m | 11.00 | -- | 1.14 | -- | 59.46 | -0.0052 | -0.0052 | 0.00007 | 0.0026 | 0.0115 | -- | 0.1307 | -- | -82.18 | -56.58 | -103.97 | -66.91 | -- | -- | -7,124.45 | -22,925.08 | -- | -- | 0.0114 | -- | 1,532.73 | 19.85 | -38.51 | -- | -4.01 | -- |
| Biotron Ltd | 1.65m | -3.44m | 18.95m | 4.00 | -- | -- | -- | 11.52 | -0.0038 | -0.0038 | 0.0018 | -0.0003 | 0.7108 | -- | -- | -- | -148.49 | -77.12 | -234.15 | -92.61 | -120.34 | -127.14 | -208.89 | -238.85 | -- | -- | -- | -- | 14.94 | 8.93 | 1.61 | -- | -- | -- |
| Invion Ltd | 3.74m | -5.63m | 20.30m | 8.00 | -- | 1.37 | -- | 5.42 | -0.0009 | -0.0009 | 0.0006 | 0.0022 | 0.217 | -- | 2.65 | -- | -32.63 | -19.46 | -34.28 | -20.50 | -- | -- | -150.33 | -70.20 | -- | -- | 0.00 | -- | -9.54 | -0.7235 | -248.51 | -- | 171.96 | -- |
| Tryptamine Therapeutics Ltd | 1.21m | -4.32m | 21.78m | -- | -- | 3.24 | -- | 18.04 | -0.0162 | -0.0162 | 0.0039 | 0.0062 | 0.2368 | -- | -- | -- | -84.69 | -- | -120.26 | -- | -- | -- | -357.70 | -- | -- | -21.62 | 0.00 | -- | -- | -- | -- | -- | -- | -- |
Data as of Sep 20 2024. Currency figures normalised to Rhythm Biosciences Ltd's reporting currency: Australian Dollar AUD
3.96%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| FIL Investment Management (Hong Kong) Ltd.as of 31 Jul 2024 | 10.01m | 3.96% |
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
